BioCentury
ARTICLE | Clinical News

Xifaxan rifaximin: Post-marketing study data

May 29, 2006 7:00 AM UTC

Data from a double-blind Mexican study in 319 U.S. travelers with acute diarrhea showed that over 5 days, median time from first dose to passage of last unformed stool (TLUS) was shorter in both combi...